Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors

BMC Medicine

Research Article

Massimo Costantini¹  Irene J. Higginson²  Charles C. Reilly²  Matthew Maddocks²  Sabrina Bajwah²  Wei Gao² 

[1] Arcispedale Santa Maria Nuova-IRCCS, Viale Umberto I, 50 – 42123, Reggio Emilia, Italy;Cicely Saunders Institute of Palliative Care, Policy & Rehabilitation, King’s College London, Bessemer Road, SE5 9PJ, London, UK;

关键词: Hospital;    Palliative care;    End of life care;    Chronic obstructive pulmonary disease;    Interstitial pulmonary diseases;    Interstitial lung disease;    Respiratory;    Policy;    Place of death;   

DOI  :  10.1186/s12916-016-0776-2

 received in 2016-10-07, accepted in 2016-12-23,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundStrategies in many countries have sought to improve palliative care and reduce hospital deaths for non-cancer patients, but their effects are not evaluated. We aimed to determine the trends and factors associated with dying in hospital in two common progressive respiratory diseases, and the impact of a national end of life care (EoLC) strategy to reduce deaths in hospital.MethodsThis population-based observational study linked death registration data for people in England dying from chronic obstructive pulmonary disease (COPD) or interstitial pulmonary diseases (IPD). We plotted age- and sex-standardised trends, assessed during the pre-strategy (2001–2004), first strategy phase (2004–2008), and strategy intensification (2009–2014) periods, and identified factors associated with hospital death using multiple adjusted proportion ratios (PRs).ResultsOver 14 years, 380,232 people died from COPD (334,520) or IPD (45,712). Deaths from COPD and IPD increased by 0.9% and 9.2% annually, respectively. Death in hospital was most common (67% COPD, 70% IPD). Dying in hospice was rare (0.9% COPD, 2.9% IPD). After a plateau in 2004–2005, hospital deaths fell (PRs 0.92–0.94). Co-morbidities and deprivation independently increased the chances of dying in hospital, with larger effects in IPD (PRs 1.01–1.55) than COPD (PRs 1.01–1.39) and dose-response gradients. The impact of multimorbidity increased over time; hospital deaths did not fall for people with two or more co-morbidities in COPD, nor one or more in IPD. Living in rural areas (PRs 0.94–0.94) or outside London (PRs, 0.89–0.98) reduced the chances of hospital death. In IPD, increased age reduced the likelihood of hospital death (PR 0.81, ≥ 85 versus ≤ 54 years); divergently, in COPD, being aged 65–74 years was associated with increased hospital deaths (PR 1.13, versus ≤ 54 years). The independent effects of sex and marital status differed for COPD versus IPD (PRs 0.89–1.04); in COPD, hospital death was associated with being married.ConclusionsThe EoLC strategy appeared to have contributed to tangible reductions in hospital deaths, but did not reach people with multimorbidity and this gap widened over time. Integrating palliative care earlier in the disease trajectory especially in deprived areas and cities, and where multimorbidity is present, should be boosted, taking into account the different demographic factors in COPD and IPD.

【 授权许可】

CC BY   
© The Author(s). 2017